|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Rockefeller University Press,
0021-9525/2001//87 $5.00
The Journal of Cell Biology, Volume 152, Number 1,
, 2001 87-96
Original Article |
WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription
cunywang{at}umich.edu
Wnt signaling plays a critical role in development and oncogenesis. Although significant progress has been made in understanding the downstream signaling cascade of Wnt signaling, little is known regarding Wnt signaling modification of the cell death machinery. Given that numerous oncogenes transform cells by providing cell survival function, we hypothesized that Wnt signaling may inhibit apoptosis. Here, we report that cells expressing Wnt-1 were resistant to cancer therapy–mediated apoptosis. Wnt-1 signaling inhibited the cytochrome c release and the subsequent caspase-9 activation induced by chemotherapeutic drugs, including both vincristine and vinblastine. Furthermore, we found that Wnt-1–mediated cell survival was dependent on the activation of β-catenin/T cell factor (Tcf) transcription. Inhibition of β-catenin/Tcf transcription by expression of the dominant-negative mutant of Tcf-4 blocked Wnt-1–mediated cell survival and rendered cells sensitive to apoptotic stimuli. These results provide the first demonstration that Wnt-1 inhibits cancer therapy–mediated apoptosis and suggests that Wnt-1 may exhibit its oncogenic potential through a mechanism of anti-apoptosis.
Key Words: β-catenin apoptosis Wnt signaling Tcf transcription cytochrome c
© 2001 The Rockefeller University Press
Abbreviations used in this paper: Apaf-1, apoptotic protease–activating factor-1; APC, adenomatous polyposis coli; β-gal, β-galactosidase; DN, dominant-negative mutant; EGFP, enhanced green fluorescent protein; GFP, green fluorescent protein; GSK-3β, glycogen synthase kinase-3β; IAP, inhibitors of apoptosis; I
B, inhibitor of
B; IKK, I
B kinase; JNK, c-Jun NH2-terminal kinase; Lef, lymphocyte enhancer factor; NF-
B, nuclear factor kappa B; PI, propidium iodide; PI3K, phosphatidyinositol-3 kinase; PS, phosphatidylserine; Tcf, T cell factor; TNF, tumor necrosis factor; VCR, vincristine; VBL, vinblastine.
Related Article
|
|